{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16562831", "DateCompleted": {"Year": "2006", "Month": "05", "Day": "08"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "69", "Issue": "3", "PubDate": {"Year": "2006", "Month": "Mar"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Role of glutamate and dopamine receptors in the psychopharmacological profile of the indole alkaloid psychollatine.", "Pagination": {"StartPage": "342", "EndPage": "345", "MedlinePgn": "342-5"}, "Abstract": {"AbstractText": ["Psychollatine (1), a new glycoside indole monoterpene alkaloid isolated from Psychotria umbellata, has shown an interesting psychopharmacological profile. This study aimed to investigate the role of NMDA glutamate and dopamine receptors in mediating the properties of 1. Psychollatine (1) was assessed for NMDA-induced seizures, MK-801-induced hyperlocomotion, amphetamine-induced lethality, and apomorphine-induced climbing behavior in mice. Psychollatine (1) (100 mg/kg) and MK-801 (0.3 mg/kg) prevented NMDA-induced seizures (P < 0.01), while 1 (100 mg/kg) attenuated the MK-801-induced hyperlocomotion (P < 0.05). Compound 1 (3 and 10 mg/kg), as well as chlorpromazine (4 mg/kg), prevented amphetamine-induced lethality (P < 0.05). Finally, 1 (10 mg/kg) (P < 0.05), MK-801 (0.2 mg/kg) (P < 0.01), and chlorpromazine (4 mg/kg) (P < 0.01) attenuated apomorphine-induced climbing behavior. The present results strongly support the involvement of NMDA glutamate receptors in the mode of action of psychollatine (1)."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Curso de P\u00f3s-gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Rio Grande do Sul, Porto Alegre/RS, Brazil."}], "Identifier": [], "LastName": "Both", "ForeName": "Fernanda L", "Initials": "FL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Meneghini", "ForeName": "Lisiane", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kerber", "ForeName": "Vitor A", "Initials": "VA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Henriques", "ForeName": "Am\u00e9lia T", "Initials": "AT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Elisabetsky", "ForeName": "Elaine", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antipsychotic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Indole Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Dopamine"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA-A"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, N-Methyl-D-Aspartate"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Serotonin"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Receptor Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "psychollatine"}, {"RegistryNumber": "6LR8C1B66Q", "NameOfSubstance": "Dizocilpine Maleate"}, {"RegistryNumber": "CK833KGX7E", "NameOfSubstance": "Amphetamine"}, {"RegistryNumber": "N21FAR7B4S", "NameOfSubstance": "Apomorphine"}, {"RegistryNumber": "Q3JTX2Q7TU", "NameOfSubstance": "Diazepam"}, {"RegistryNumber": "U42B7VYA4P", "NameOfSubstance": "Chlorpromazine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Amphetamine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antipsychotic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Apomorphine"}, {"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chlorpromazine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Diazepam"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dizocilpine Maleate"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Indole Alkaloids"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Memory"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Psychopharmacology"}, {"QualifierName": ["chemistry"], "DescriptorName": "Psychotria"}, {"QualifierName": ["physiology"], "DescriptorName": "Receptors, Dopamine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, GABA-A"}, {"QualifierName": ["physiology"], "DescriptorName": "Receptors, N-Methyl-D-Aspartate"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, Serotonin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Serotonin Receptor Agonists"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "3", "Day": "28", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "9", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "3", "Day": "28", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16562831", "10.1021/np050291v"]}}], "PubmedBookArticle": []}